Bardy Diagnostics Stock

bardydx.comHealthcareFounded: 1900Funding to Date: $84.02MM

Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 14 days.

Register for Details

For more details on financing and valuation for Bardy Diagnostics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Bardy Diagnostics.

Register Today

Team

Management Team

Mark Querry
Chief Financial Officer
Ken Nelson
Chief Commercial Officer
Gust Bardy MD
Founder, Chief Executive Officer, Chief Medical Officer and Chairman
Jonathan Wu
Director, Marketing
Alan Levy Ph.D
Executive Director
Edward Vertatschitsch Ph.D
Chief Operating Officer
Mark Handfelt
Chief Operating Officer

Board Members

David Tamburri
LaViolette Paul
Warren Watson
Garheng Kong MD
HealthQuest Capital
Rubal Bedi
Ascension Ventures
Gerry Brunk
Lumira Ventures
Gust Bardy MD
Rurik Vandevenne
River Cities Capital Funds

Other companies like Bardy Diagnostics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM

News

/PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the...
Bardy Diagnostics, a Seattle-based business developing a cardiac monitor and arrhythmia detection device, announced this week it has raised $35.5 million